We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£186.89
This is the most expensive it has ever been. Walk away.
£187 today · previous high £187 · all-time low £185
Monoamine Oxidase Inhibitors: Clinical Pharmacology, Benefits, & Potential Health Risks
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 42 days · 42 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 42 days • 3 price levels
Price Analysis
Most common price: £185 (23 days, 54.8%)
Price range: £185 - £187
Price levels: 3 different prices over 42 days
Description
Product Specifications
- Format
- hardcover
- ASIN
- 1634836006
- Domain
- Amazon UK
- Release Date
- 01 January 2016
- Listed Since
- 15 October 2015
Barcode
No barcode data available
Similar Products You Might Like
Translational Neuropsychopharmacology: 28 (Current Topics in Behavioral Neurosciences, 28)
Springer
Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders
Elsevier
In Vivo Neuropharmacology and Neurophysiology: 121 (Neuromethods, 121)
Humana
In Vivo Neuropharmacology and Neurophysiology: 121 (Neuromethods, 121)
Humana
Advances in Neuropharmacology: Drugs and Therapeutics
CRC Press
Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects (Experimental and Clinical Neuroscience)
Humana
Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects (Experimental and Clinical Neuroscience)
Humana
5-HT2C Receptors in the Pathophysiology of CNS Disease: 22 (The Receptors, 22)
Humana
Sigma Receptors: Their Role in Disease and as Therapeutic Targets: 964 (Advances in Experimental Medicine and Biology, 964)
Springer
Serotonin: From Cell Biology to Pharmacology and Therapeutics
Springer
Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease
Elsevier
Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)
Springer
Cortico-Subcortical Dynamics in Parkinson’s Disease (Contemporary Neuroscience)
Humana
Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)
Springer
Dopamine Receptor Technologies: 96 (Neuromethods, 96)
Humana
Serotonin Receptors in Neurobiology (Frontiers in Neuroscience)
CRC Press
Chemical Biology of Neurodegeneration: Molecular Approach
Wiley
Cognition and Mood Interactions
Neurobiology of DOPA as a Neurotransmitter
CRC Press
Clinical Studies and Therapies in Parkinson's Disease: Translations from Preclinical Models
Elsevier
Psychiatric Aspects Of Neurologic Diseases: Practical Approaches to Patient Care
Oxford University Press
Brain Acetylcholine and Neuropsychiatric Disease
Springer
Biochemical Approaches for Glutamatergic Neurotransmission: 130 (Neuromethods, 130)
Humana
Biochemical Approaches for Glutamatergic Neurotransmission: 130 (Neuromethods, 130)
Humana